These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16182742

  • 21. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE, Tofteng F, Strauss GI, Larsen FS.
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [Abstract] [Full Text] [Related]

  • 22. Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports.
    Pugliese F, Ruberto F, Perrella SM, Cappannoli A, Bruno K, Martelli S, Celli P, Summonti D, D'Alio A, Tosi A, Novelli G, Morabito V, Poli L, Rossi M, Berloco PB, Pietropaoli P.
    Transplant Proc; 2007 Oct; 39(6):2042-4. PubMed ID: 17692688
    [Abstract] [Full Text] [Related]

  • 23. Is MARS system enough for A. phalloides-induced liver failure treatment?
    Sorodoc L, Lionte C, Sorodoc V, Petris O, Jaba I.
    Hum Exp Toxicol; 2010 Oct; 29(10):823-32. PubMed ID: 20179021
    [Abstract] [Full Text] [Related]

  • 24. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure.
    Schmidt LE, Svendsen LB, Sørensen VR, Hansen BA, Larsen FS.
    Liver Transpl; 2001 Aug; 7(8):709-12. PubMed ID: 11510016
    [Abstract] [Full Text] [Related]

  • 25. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
    Gaspari R, Cavaliere F, Sollazzi L, Perilli V, Melchionda I, Agnes S, Gasbarrini A, Avolio AW.
    Transplant Proc; 2009 Aug; 41(1):253-8. PubMed ID: 19249528
    [Abstract] [Full Text] [Related]

  • 26. Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.
    Roth GA, Faybik P, Hetz H, Hacker S, Ankersmit HJ, Bacher A, Thalhammer T, Krenn CG.
    Dig Liver Dis; 2009 Jun; 41(6):417-23. PubMed ID: 19019743
    [Abstract] [Full Text] [Related]

  • 27. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study.
    Faybik P, Bacher A, Kozek-Langenecker SA, Steltzer H, Krenn CG, Unger S, Hetz H.
    Crit Care; 2006 Feb; 10(1):R24. PubMed ID: 16469128
    [Abstract] [Full Text] [Related]

  • 28. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.
    Tan HK, Yang WS, Chow P, Lui HF, Choong HL, Wong KS.
    Artif Organs; 2007 Mar; 31(3):193-9. PubMed ID: 17343694
    [Abstract] [Full Text] [Related]

  • 29. Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure.
    Hessel FP, Bramlage P, Wasem J, Mitzner SR.
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):213-20. PubMed ID: 19773666
    [Abstract] [Full Text] [Related]

  • 30. [Clinical research of patients with acute or chronic hepatic failure treated with molecular adsorbent recirculating system].
    Zhou X, Wang X, Yang Y, Zhao L, Miao J, Ding J, Fan D.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):213-5. PubMed ID: 12113683
    [Abstract] [Full Text] [Related]

  • 31. Liver support technology--an update.
    Rozga J.
    Xenotransplantation; 2006 Sep; 13(5):380-9. PubMed ID: 16925661
    [Abstract] [Full Text] [Related]

  • 32. The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure.
    Di Campli C, Zocco MA, Gaspari R, Novi M, Candelli M, Santoliquido A, Flore R, Tondi P, Proietti R, Gasbarrini G, Pola P, Gasbarrini A.
    Transplant Proc; 2005 Sep; 37(6):2551-3. PubMed ID: 16182740
    [Abstract] [Full Text] [Related]

  • 33. Albumin dialysis without anticoagulation in high-risk patients: an observational study.
    Tan HK, Yang WS, Choong HL, Wong KS.
    Artif Organs; 2012 Mar; 36(3):E83-8. PubMed ID: 21091517
    [Abstract] [Full Text] [Related]

  • 34. Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure.
    Tsai MH, Chen YC, Wu CS, Ho YP, Fang JT, Lien JM, Yang C, Chu YY, Liu NJ, Lin CH, Chiu CT, Chen PC.
    Int J Clin Pract; 2005 Nov; 59(11):1289-94. PubMed ID: 16236082
    [Abstract] [Full Text] [Related]

  • 35. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis.
    Vaid A, Chweich H, Balk EM, Jaber BL.
    ASAIO J; 2012 Nov; 58(1):51-9. PubMed ID: 22210651
    [Abstract] [Full Text] [Related]

  • 36. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
    Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y.
    Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386
    [Abstract] [Full Text] [Related]

  • 37. Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.
    Donati G, La Manna G, Cianciolo G, Grandinetti V, Carretta E, Cappuccilli M, Panicali L, Iorio M, Piscaglia F, Bolondi L, Colì L, Stefoni S.
    Artif Organs; 2014 Feb; 38(2):125-34. PubMed ID: 23834711
    [Abstract] [Full Text] [Related]

  • 38. Artificial liver support system in acute liver failure patients waiting liver transplantation.
    Montejo González JC, Catalán González M, Meneu Díaz JC, Moreno Elola-Olaso A, De la Cruz J, Moreno González E.
    Hepatogastroenterology; 2009 Feb; 56(90):456-61. PubMed ID: 19579620
    [Abstract] [Full Text] [Related]

  • 39. Successful treatment of an adult with Amanita phalloides-induced fulminant liver failure with molecular adsorbent recirculating system (MARS).
    Lionte C, Sorodoc L, Simionescu V.
    Rom J Gastroenterol; 2005 Sep; 14(3):267-71. PubMed ID: 16200238
    [Abstract] [Full Text] [Related]

  • 40. Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure.
    Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, Schmitt CP.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3633-9. PubMed ID: 21421589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.